Ivabradine: Do the Benefits Outweigh the Risks?

Alshammari, Thamir M

Alshammari, Thamir M.

Affiliation

Alshammari TM; 1 Department of Clinical Pharmacy, College of Pharmacy, University of Hail, Hail, Saudi Arabia.

J Cardiovasc Pharmacol Ther ; 22(3): 210-218, 2017 05.

Article in En | MEDLINE | ID: mdl-27698078

Subject(s)

Angina Pectoris/drug therapy; Benzazepines/therapeutic use; Cardiovascular Agents/therapeutic use; Heart Failure/drug therapy; Angina Pectoris/diagnosis; Angina Pectoris/physiopathology; Benzazepines/adverse effects; Bradycardia/chemically induced; Bradycardia/physiopathology; Cardiovascular Agents/adverse effects; Heart Failure/diagnosis; Heart Failure/physiopathology; Heart Rate/drug effects; Humans; Ivabradine; Patient Safety; Recovery of Function; Risk Assessment; Risk Factors; Treatment Outcome; Ventricular Function, Left/drug effects

Key words

CHF; angina; benefitrisk balance; ivabradine; regulatory action

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Benzazepines / Cardiovascular Agents / Heart Failure / Angina Pectoris Type of study: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limits: Humans Language: En Journal: J Cardiovasc Pharmacol Ther Journal subject: ANGIOLOGIA / CARDIOLOGIA / FARMACOLOGIA Year: 2017 Document type: Article Affiliation country: Saudi Arabia Country of publication: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google